Skip to content
Biocidium Biopharmaceuticals Inc. Logo
  • Home
  • Company
  • Products
    • Pipeline
    • Antibiotics
    • Antifungals
    • Oncology
  • Partnering
  • News
  • Contact

CRE

  • Acinetobacter baumannii

A. baumannii, P. aeruginosa outnumber CRE in US hospitals

Recent data showed that Acinetobacter baumannii and Pseudomonas aeruginosa — both of which landed the top spots on WHO’s list of “priority pathogens” in critical need of new therapies [...]

Superbug Outbreak at LA Hospital

'Superbug' outbreak raises questions about medical scope By ALICIA CHANG Feb. 19, 2015 11:08 PM EST Two people have died and five more have been [...]

Nightmare Bacteria – Washington Post publishes serious warning about antibiotic-resistant bacteria

The Washington Post just published a serious and scary opinion piece about the growing thread of anti-biotic resistant bacteria, and the increasing severity in both [...]

Antibiotic resistance: The last resort

"Health officials are watching in horror as bacteria become resistant to powerful carbapenem antibiotics — one of the last drugs on the shelf." Via: Nature.com [...]

Where ‘Nightmare Bacteria’ Came From, And How Our Inattention Helped Them Emerge

Via Wired Magazine BY MARYN MCKENNA 07.25.13 Cast your minds back a few months ago, to when the director of the US Centers for Disease [...]

Emerging superbug requires urgent action, CDC says

By Rachael Rettner, MyHealthNewsDaily Tue, Mar 05 2013 at 3:00 PM, via Mother Nature Network During the first six months of 2012, nearly 200 U.S. [...]

In Ranking of Superbugs, Klebsiella Takes the Lead

Story by: by Karen Blum, Pharmacy Practice News Hospital pharmacists face several challenges in helping manage antibiotic-resistant, gram-negative superbugs that produce carbapenemases. One of the most [...]

  • Dirty hospital rooms a top concern for Canadians

Dirty hospital rooms a top concern for Canadians

Many of those who answered a fifth estate survey on patient experiences in hospital said they found patient rooms and bathrooms were not cleaned [...]

CRE in the news – Links to related stories

CRE is a hot topic these days, with a steady stream of both science-based publications and mainstream news agencies reporting on the superbug and the [...]

Superbugs Are a ‘Costly War We Can’t Win’: Doctors

CNBC published a news item on Thursday April 4, expressing the challenge that superbugs, MRSA and CRE in particular, pose to our health care system. Dr. [...]

12Next

Categories

  • Antibiotic resistance (82)
    • CDI (0)
    • CRE (12)
    • MRSA (15)
    • VRE (3)
  • Antifungal (8)
  • Antimicrobial general reference (13)
  • Biocidium company news (1)
  • Biocidium product updates (1)
  • Careers (0)
  • Oncology (10)
  • Science and Industry developments (34)
  • Uncategorized (0)

Contact Info

Email: info@biocidium.com

Web: Contact Us

BIOCIDIUM

Biocidium is a clinical-stage bio-pharmaceutical company focused on the discovery & development of novel antibiotics, antifungals and cancer treatments. Our primary products are developed for the treatment of multi-drug resistant (MDR) bacterial infections as well as breakthrough treatments for cancer and fungal infections
Terms of Use | Privacy Policy

NEWS

  • Genomic sequencing reveals MRSA spread within, between ICUs
  • The dangerous legacy of COVID-19: A rise in antimicrobial resistance
  • 3 cases of pan-resistant C. auris identified in New York
  • Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019

CONTACT

Email: info@biocidium.com

Web: Contact us

Copyright ©2021 Biocidium Biopharmaceuticals | All Rights Reserved | info@biocidium.com | media
Page load link